The DOI matches its Crossref record; 59 of the 62 references it cites were found in a registry or an index.
Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide
Abstract
Administration of bacterial lipopolysaccharide (LPS) to laboratory animals and cultured macrophages is known to induce the production of nitric oxide (NO) from inducible nitric oxide synthase (iNOS). Here we show that pre-treatment with Ginkgo biloba extract (EGb 761) suppresses the in vivo production of NO (measured by the Griess reaction) after challenge with LPS. In order to begin to understand the mechanism of this inhibition, we evaluated in vitro effects of EGb 761 and its flavonoid component, quercetin, on LPS-treated RAW 264.7 macrophages. Pre-treatment with EGb 761 or quercetin dose-dependently inhibited NO release. Both substances scavenged NO generated from the decomposition of sodium nitroprusside. Western analysis showed that EGb 761 and quercetin inhibited LPS-induced levels of iNOS protein. Northern blotting demonstrated that EGb 761 and quercetin decreased LPS-induced iNOS mRNA levels without altering the half-life. Activation of mitogen activated protein kinases (MAPKs) and the redox-sensitive transcription factors, nuclear factor-kappaB (NF-kappaB) and activator protein 1 (AP-1) are key events in the signal transduction pathways mediating iNOS induction. In our studies, both EGb 761 and quercetin inhibited p38 MAPK activity, which is necessary for iNOS expression in LPS-stimulated RAW 264.7 macrophages. However, differences in the response of NF-kappaB, AP-1, and Jun N-terminal kinase/stress activated protein kinase (JNK/SAPK) and its downstream substrates to EGb 761 and quercetin suggest that quercetin is not the sole component responsible for the in vivo inhibition of LPS-induced iNOS activation by EGb 761.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In macrophages and other types of cells, LPS activates three subclasses of MAPKs: extracellular signal-regulated kinase (ERK), c-Jun-terminal kinase (JNK) and p38. Studies have revealed that some compounds are able to suppress proinflammatory cytokines and NF-κB, to inhibit the COX-2 and iNOS expression inhibiting some of these MAPKS [129,130,131].”
From Antioxidant and Anti-Inflammatory Activities of Essential Oils: A Short Review (2010) · cites this paper as [129]
Citations
Cites
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212
Antioxidant and redox regulation of gene transcription
Sen, C. K., & Packer, L. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.7.8635688 · Cited by 1,972
Regulation of biosynthesis of nitric oxide.
Nathan, C., & Xie, Q. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36703-0 · Cited by 1,669
Xie, Q. W., Whisnant, R., & Nathan, C. F. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.6.1779 · Cited by 1,118
Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W., & Murphy, W. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9730 · Cited by 1,066
The Nitric Oxide-Scavenging Properties of Ginkgo Biloba Extract EGb 761
Marcocci, L., Maguire, J. J., Droy-Lefaix, M. T., & Packer, L. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1764 · Cited by 1,053
Is NF-kappaB the sensor of oxidative stress?
Li, N., & Karin, M. (1999) · PubMed · Cited by 786
Bhat, N. R., Zhang, P., Lee, J. C., & Hogan, E. L. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01633.1998 · Cited by 714
Is NF‐κB the sensor of oxidative stress?
Li, N., & Karin, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1137 · Cited by 702
Macrophages and Inflammatory Mediators in Tissue Injury
Laskin, D. L., & Pendino, K. J. (1995) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.003255 · Cited by 618
Mh, L. T. (1996) · Cited by 600
Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties
Manach, C., Morand, C., Crespy, V., Demigné, C., Texier, O., Regerat, F., & Rémésy, C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00367-6 · Cited by 586
The Efficacy of Ginkgo biloba on Cognitive Function in Alzheimer Disease
Oken, B., Storzbach, D. M., & Kaye, J. A. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1409 · Cited by 585
Lin, Y., & Lin, J. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.465 · Cited by 570
Lin, Y., & Lin, J. (1997) · PubMed · Cited by 539
The high-output nitric oxide pathway: role and regulation
Xie, Q. W., & Nathan, C. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.5.576 · Cited by 510
Kleijnen, J., & Knipschild, P. G. (1992) · The Lancet · doi:10.1016/0140-6736(92)93158-j · Cited by 464
TLR6: A novel member of an expanding Toll-like receptor family
Takeuchi, O., Kawai, T., Sanjo, H., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Takeda, K., & Akira, S. (1999) · Gene · doi:10.1016/s0378-1119(99)00098-0 · Cited by 429
Absorption and disposition kinetics of the dietary antioxidant quercetin in man
Hollman, P. C. H., Gaag, M. V. D., Mengelers, M. J. B., van Trijp, J. M. P., de Vries, J. H. M., & Katan, M. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)00129-3 · Cited by 401
Kawada, N., Seki, S., Inoue, M., & Kuroki, T. (1998) · Hepatology · doi:10.1002/hep.510270512 · Cited by 397
Weinstein, S. L., Sanghera, J. S., Lemke, K., DeFranco, A. L., & Pelech, S. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42133-3 · Cited by 396
Ajizian, S., English, B. K., & Meals, E. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/314659 · Cited by 345
Plasma metabolites of quercetin and their antioxidant properties
Morand, C., Crespy, V., Manach, C., Besson, C., Demigné, C., & Rémésy, C. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.1.r212 · Cited by 333
Chen, Y., Yang, L., & Lee, T. J.-F. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00255-0 · Cited by 323
Both Erk and p38 Kinases Are Necessary for Cytokine Gene Transcription
Carter, A. B., Monick, M. M., & Hunninghake, G. W. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.4.3420 · Cited by 305
Wadsworth, T. L., & Koop, D. R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00002-7 · Cited by 302
Chen, C., & Wang, J.-K. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12172-4 · Cited by 291
Leone, A., Palmer, R. M. J., Knowles, R. G., Francis, P. L., Ashton, D., & Moncada, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54352-0 · Cited by 290
Su, G. L., Klein, R., Aminlari, A., Zhang, H. Y., Steinstraesser, L., Alarcon, W. H., Remick, D., & Wang, S. C. (2000) · Hepatology · doi:10.1053/he.2000.5634 · Cited by 280
Sherman, M. P., Aeberhard, E. E., Wong, V., Griscavage, J. M., & Ignarro, L. J. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1359 · Cited by 249
Transport of Quercetin and Its Glucosides across Human Intestinal Epithelial Caco-2 Cells
Walgren, R. A., Walle, U. K., & Walle, T. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00048-3 · Cited by 249
CHEN, CHEN, & Lin, W. (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00747.x · Cited by 240
Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761
Maitra, I., Marcocci, L., Droy-Lefaix, M. T., & Packer, L. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00089-i · Cited by 238
Pietri, S., Maurelli, E., Drieu, K., & Culcasi, M. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0316 · Cited by 236
Evidence of increased nitric oxide production in patients with the sepsis syndrome.
Evans, T. J., Carpenter, A., Kinderman, H., & Cohen, J. (1993) · PubMed · Cited by 222
Bioavailability of the dietary antioxidant flavonol quercetin in man
Hollman, P. C. H., van Trijp, J. M. P., Mengelers, M. J. B., de Vries, J. H. M., & Katan, M. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04644-2 · Cited by 209
Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway
Kobuchi, H., Roy, S., Sen, C. K., Nguyen, H. G., & Packer, L. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.3.c403 · Cited by 197
Chu, S. C., Marks-Kończalik, J., Wu, H.-P., Banks, T. C., & Moss, J. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9062 · Cited by 166
Weisz, A., Oguchi, S., Cicatiello, L., & Esumi, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37197-1 · Cited by 163
Molecular mechanisms in the antiproliferative action of quercetin
Csókay, B., Prajda, N., Weber, G., & Oláh, E. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00230-0 · Cited by 162
Kobuchi, H., Droy-Lefaix, M. T., Christen, Y., & Packer, L. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00873-8 · Cited by 154
Wadsworth, T. L., McDonald, T. L., & Koop, D. R. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00734-1 · Cited by 147
Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets
de Vrie, J. H. M., Janssen, P., Hollman, P. C. H., van Staveren, W. A., & Katan, M. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04645-4 · Cited by 140
Preparation and Definition of Ginkgo Biloba Extract
Drieu, K. (1988) · Springer eBooks · doi:10.1007/978-3-642-73686-5_3 · Cited by 139
Current Status of Antioxidant Therapy for Alzheimer's Disease
Pitchumoni, S., & Doraiswamy, P. M. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb01544.x · Cited by 112
Paul, A., Cuenda, A., Bryant, C. E., Murray, J., Chilvers, E. R., Cohen, P., Gould, G. W., & Plevin, R. J. (1999) · Cellular Signalling · doi:10.1016/s0898-6568(99)00018-2 · Cited by 104
Akarasereenont, P., Mitchell, J. A., Appleton, I., Thiemermann, C., & Vane, J. R. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17169.x · Cited by 93
Natural substances in psychiatry (Ginkgo biloba in dementia).
Itil, T. M., & Martorano, D. (1995) · PubMed · Cited by 83
Jeon, Y. J., Kim, Y. K., Lee, M., Park, S. M., Han, S., & Kim, H. M. (2000) · PubMed · Cited by 79
Down-Regulation of Cytochrome P450 mRNAs and Proteins in Mice Lacking a Functional NOS2 Gene
Sewer, M. B., Barclay, T. B., & Morgan, E. T. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.273 · Cited by 74
Endotoxin opens the Toll gates to innate immunity
Ulevitch, R. J. (1999) · Nature Medicine · doi:10.1038/5504 · Cited by 70
Pincemail, J., Thirion, A., Dupuis, M., Braquet, P. G., Drieu, K., & Deby, C. M. T. (1987) · Cellular and Molecular Life Sciences · doi:10.1007/bf01942843 · Cited by 65
Kuo, S., Morehouse, H. F., & Lin, C.-P. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00183-3 · Cited by 56
Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardium
Tósaki, Á., Páli, T., & Droy-Lefaix, M. T. (1996) · Diabetologia · doi:10.1007/s001250050567 · Cited by 51
Musonda, C., Helsby, N. A., & Chipman, J. (1997) · Human & Experimental Toxicology · doi:10.1177/096032719701601202 · Cited by 37
Sasaki, K., Wada, K., Hatta, S., Ohshika, H., & Masanobu, H. A. G. A. (1997) · PubMed · Cited by 31
EGb 761 and the Recovery of Ion Imbalance in Ischemic Reperfused Diabetic Rat Retina
Szabo, M. E., Droy-Lefaix, M. T., & Doly, M. (2009) · Ophthalmic Research · doi:10.1159/000267606 · Cited by 17
Lee, Y. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00452-3 · Cited by 14
Kobuchi, H., & Packer, L. (1997) · IUBMB Life · doi:10.1080/15216549700203911 · Cited by 11
Research works printed but not linked: 1
- Xie, 1994, Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase, J. Biol. Chem., 269, 4705, 10.1016/S0021-9258(17)37600-7 · DOI · Paper page
Cited by
Sorted by citations
Anti-inflammatory Plant Flavonoids and Cellular Action Mechanisms
Kim, H. P., Son, K. H., Chang, H. W., & Kang, S. S. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj04003x · Cited by 1,018
Antioxidant and Anti-Inflammatory Activities of Essential Oils: A Short Review
Miguel, M. G. (2010) · Molecules · doi:10.3390/molecules15129252 · Cited by 933
Flavonoids as anti-inflammatory agents
Serafini, M., Peluso, I., & Raguzzini, A. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s002966511000162x · Cited by 826
Inflammatory Disease Processes and Interactions with Nutrition
Calder, P. C., Albers, R., Antoine, J., Blum, S., Bourdet‐Sicard, R., Ferns, G. A., Folkerts, G., Friedmann, P. S., Frost, G. S., Guarner, F., et al. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509377867 · Cited by 585
“Quercetin has been shown to affect iNOS expression by inhibiting p38 MAPK and TNF-a from LPS-induced RAW cells by inhibiting jun N-terminal kinase/SAPK and Ap-1 DNA binding((376,377)).”
BackgroundFruit polyphenols, immunity and inflammation
González-Gallego, J., García-Mediavilla, M. V., Sánchez-Campos, S., & Tuñón, M. J. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510003910 · Cited by 387
“It has been shown that quercetin inhibits iNOS expression through inhibition of p38 MAPK and blocks AP-1 binding in LPS-induced RAW cells by inhibiting c-Jun N-terminal kinase((60)).”
Background
Metadata
- Authors
- Wadsworth, T. L., & Koop, D. R.
- Affiliations
- Oregon Health & Science University (US)
- Corresponding author
- Koop, Dennis R
- Venue
- Chemico-Biological Interactions
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 137
- Issue
- 1
- Pages
- 43-58
- ISSN
- 0009-2797 (ISSN-L)
- OpenAlex
- W2035027020
- Cited by
- 116
- References
- 62
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 2 · 2015: 6 · 2014: 3 · 2013: 7 · 2012: 5
- FWCI
- 19.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemico-Biological Interactions (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA 08608)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Ginkgo biloba and Cashew Applications
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Pharmacology (medical) › Flavonoids in Medical Research
- Keywords
- Ginkgo biloba extract EGb 761, quercetin, lipopolysaccharide, nitric oxide, inducible nitric oxide synthase, macrophages, RAW 264.7 macrophages, p38 MAPK, NF-κB, AP-1, SAPK/JNK, flavonoids, anti-inflammatory activity, signal transduction
- MeSH terms
- Ginkgo Extract, Animals, Cells, Cultured, Dose-Response Relationship, Drug, Enzyme Inhibitors, Imidazoles, Lipopolysaccharides, Macrophages, Male, Mice, Inbred C57BL, Nitric Oxide, Nitroprusside, Plant Extracts, Pyridines, Quercetin, Tumor Necrosis Factor-alpha, Free Radical Scavengers, Nitric Oxide Synthase, Nitric Oxide Donors, Ginkgo biloba, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review